239 related articles for article (PubMed ID: 38002042)
1. Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD).
Choubey M; Tirumalasetty MB; Bora NS; Bora PS
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002042
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy.
Choubey M; Bora P
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371562
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice.
Fu Z; Liegl R; Wang Z; Gong Y; Liu CH; Sun Y; Cakir B; Burnim SB; Meng SS; Löfqvist C; SanGiovanni JP; Hellström A; Smith LEH
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3862-3870. PubMed ID: 28763559
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory role of adiponectin peptide I on rat choroidal neovascularization.
Lyzogubov VV; Tytarenko RG; Bora NS; Bora PS
Biochim Biophys Acta; 2012 Aug; 1823(8):1264-72. PubMed ID: 22633972
[TBL] [Abstract][Full Text] [Related]
5. Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration.
Logan C; Lyzogubov V; Bora N; Bora P
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139070
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II.
Lyzogubov VV; Tytarenko RG; Thotakura S; Viswanathan T; Bora NS; Bora PS
Cell Biol Int; 2009 Jul; 33(7):765-71. PubMed ID: 19422927
[TBL] [Abstract][Full Text] [Related]
7. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
8. Expression of adiponectin and its receptors in type 1 diabetes mellitus in human and mouse retinas.
Lin T; Qiu Y; Liu Y; Mohan R; Li Q; Lei B
Mol Vis; 2013; 19():1769-78. PubMed ID: 23922494
[TBL] [Abstract][Full Text] [Related]
9. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
10. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
11. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
Rohrer B
Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
[TBL] [Abstract][Full Text] [Related]
12. [Age-related Macular Degeneration in the Japanese].
Yoshimura N
Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
14. Choroidal Mast Cells and Pathophysiology of Age-Related Macular Degeneration.
Malih S; Song YS; Sorenson CM; Sheibani N
Cells; 2023 Dec; 13(1):. PubMed ID: 38201254
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity.
Katira A; Tan PH
Expert Opin Ther Targets; 2015; 19(8):1105-25. PubMed ID: 25952656
[TBL] [Abstract][Full Text] [Related]
16. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
Feng L; Hu JH; Chen J; Xie X
J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
[TBL] [Abstract][Full Text] [Related]
17. AdipoRs- a potential therapeutic target for fibrotic disorders.
Ma L; Li X; Bai Z; Lin X; Lin K
Expert Opin Ther Targets; 2019 Feb; 23(2):93-106. PubMed ID: 30569772
[No Abstract] [Full Text] [Related]
18. A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration.
Heloterä H; Kaarniranta K
Cells; 2022 Nov; 11(21):. PubMed ID: 36359849
[TBL] [Abstract][Full Text] [Related]
19. Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration.
Kambhampati SP; Bhutto IA; Wu T; Ho K; McLeod DS; Lutty GA; Kannan RM
J Control Release; 2021 Jul; 335():527-540. PubMed ID: 34058271
[TBL] [Abstract][Full Text] [Related]
20. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
